Elizabeth M. Lamos

591 total citations
34 papers, 413 citations indexed

About

Elizabeth M. Lamos is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Elizabeth M. Lamos has authored 34 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Elizabeth M. Lamos's work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (8 papers). Elizabeth M. Lamos is often cited by papers focused on Diabetes Treatment and Management (15 papers), Diabetes Management and Research (13 papers) and Pancreatic function and diabetes (8 papers). Elizabeth M. Lamos collaborates with scholars based in United States, Australia and Sint Maarten. Elizabeth M. Lamos's co-authors include Stephen N. Davis, Lisa M. Younk, Kashif M. Munir, Rana Malek, David Levitt, Маниге Кониг, Maka S. Hedrington, Stephanie Aleskow Stein, Eli N. Perencevich and Anthony D. Harris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Endocrinology and Infection Control and Hospital Epidemiology.

In The Last Decade

Elizabeth M. Lamos

33 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth M. Lamos United States 13 263 108 97 45 39 34 413
Zelija Velija-Ašimi Bosnia and Herzegovina 12 161 0.6× 53 0.5× 86 0.9× 103 2.3× 19 0.5× 39 378
Soumik Goswami India 10 149 0.6× 56 0.5× 105 1.1× 22 0.5× 12 0.3× 35 380
Natalie Houwing United Kingdom 8 129 0.5× 130 1.2× 71 0.7× 30 0.7× 77 2.0× 11 550
Kyriakos Kazakos Greece 11 223 0.8× 62 0.6× 83 0.9× 30 0.7× 34 0.9× 28 474
Yue-Hua Huang China 6 181 0.7× 56 0.5× 125 1.3× 14 0.3× 37 0.9× 12 531
Licy L. Yanes Cardozo United States 13 147 0.6× 40 0.4× 62 0.6× 161 3.6× 25 0.6× 35 407
Rok Herman Slovenia 8 115 0.4× 49 0.5× 93 1.0× 103 2.3× 30 0.8× 18 344
Ali Shamsa Iran 10 109 0.4× 64 0.6× 95 1.0× 43 1.0× 52 1.3× 33 351
Aditi Parulkar United States 2 292 1.1× 54 0.5× 207 2.1× 14 0.3× 65 1.7× 5 502
Vishal Bhatia United States 10 266 1.0× 36 0.3× 88 0.9× 113 2.5× 102 2.6× 24 517

Countries citing papers authored by Elizabeth M. Lamos

Since Specialization
Citations

This map shows the geographic impact of Elizabeth M. Lamos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. Lamos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. Lamos more than expected).

Fields of papers citing papers by Elizabeth M. Lamos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth M. Lamos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. Lamos. The network helps show where Elizabeth M. Lamos may publish in the future.

Co-authorship network of co-authors of Elizabeth M. Lamos

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth M. Lamos. A scholar is included among the top collaborators of Elizabeth M. Lamos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth M. Lamos. Elizabeth M. Lamos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamos, Elizabeth M. & Rana Malek. (2024). Assessment of Online Transgender Healthcare Teaching Modules for Internal Medicine Residents and Fellows. 14(2). 259–268. 1 indexed citations
2.
Malek, Rana, et al.. (2023). Challenges of Gender-Affirming Care in Incarcerated Transgender People. Endocrinology and Metabolism Clinics of North America. 52(4). 677–687.
3.
Malek, Rana, et al.. (2022). ODP410 Exposure to Transgender Teaching in Internal Medicine Residents and Established Providers. Journal of the Endocrine Society. 6(Supplement_1). A660–A661. 3 indexed citations
4.
Lamos, Elizabeth M., et al.. (2021). Two Cases of Armour Thyroid Interference in Thyroglobulin Monitoring for Thyroid Cancer. SHILAP Revista de lepidopterología. 2021(1). 5–6. 2 indexed citations
5.
Levitt, David, et al.. (2021). Knowledge of Hemoglobin A1c and Glycemic Control in an Urban Population. Cureus. 13(3). e13995–e13995. 4 indexed citations
6.
Lamos, Elizabeth M., et al.. (2021). Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. Expert Review of Clinical Pharmacology. 14(7). 837–852. 6 indexed citations
7.
Lamos, Elizabeth M., et al.. (2020). The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD. CEN Case Reports. 9(3). 271–277. 3 indexed citations
8.
Lamos, Elizabeth M., Maka S. Hedrington, & Stephen N. Davis. (2019). An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors. Expert Opinion on Drug Safety. 18(8). 691–701. 24 indexed citations
9.
Lamos, Elizabeth M., et al.. (2017). Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation. Diabetes Metabolic Syndrome and Obesity. Volume 10. 13–17. 4 indexed citations
10.
Davis, Stephen N., Elizabeth M. Lamos, & Lisa M. Younk. (2016). Concentrated insulins: the new basal insulins. Therapeutics and Clinical Risk Management. 12. 389–389. 33 indexed citations
11.
Croft, Lindsay, Hannah Day, Lisa Pineles, et al.. (2016). Frequency of Adverse Events Before, During, and After Hospital Admission. Southern Medical Journal. 109(10). 631–635. 3 indexed citations
12.
Lamos, Elizabeth M., Lisa M. Younk, Donna B. Tate, & Stephen N. Davis. (2015). Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals. Journal of Clinical & Translational Endocrinology. 3. 14–20. 4 indexed citations
13.
Lamos, Elizabeth M., David Levitt, & Kashif M. Munir. (2015). A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters. Primary care diabetes. 10(1). 60–65. 38 indexed citations
14.
Кониг, Маниге, et al.. (2015). Third-Trimester Intraplacental Choriocarcinoma Presenting With Respiratory Failure and Hyperthyroidism. AACE Clinical Case Reports. 2(3). e233–e236. 1 indexed citations
15.
Stein, Stephanie Aleskow, Elizabeth M. Lamos, & Stephen N. Davis. (2014). Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology. 10(4). 599–608. 5 indexed citations
16.
Younk, Lisa M., Elizabeth M. Lamos, & Stephen N. Davis. (2014). The cardiovascular effects of insulin. Expert Opinion on Drug Safety. 13(7). 955–966. 17 indexed citations
17.
Lamos, Elizabeth M., Lisa M. Younk, & Stephen N. Davis. (2014). Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes. Expert Opinion on Investigational Drugs. 23(6). 875–882. 36 indexed citations
18.
Кониг, Маниге, et al.. (2013). An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications?. Current Diabetes Reviews. 9(5). 371–381. 35 indexed citations
19.
Lamos, Elizabeth M., Lisa M. Younk, & Stephen N. Davis. (2013). Canagliflozin, an inhibitor of sodium–glucose cotransporter 2, for the treatment of type 2 diabetes mellitus. Expert Opinion on Drug Metabolism & Toxicology. 9(6). 763–775. 45 indexed citations
20.
Lamos, Elizabeth M., Stephanie Aleskow Stein, & Stephen N. Davis. (2012). Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. 13(17). 2545–2554. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zelija Velija-Ašimi Breakdown of academic impact, for papers by Soumik Goswami Breakdown of academic impact, for papers by Natalie Houwing Breakdown of academic impact, for papers by Kyriakos Kazakos Breakdown of academic impact, for papers by Yue-Hua Huang Breakdown of academic impact, for papers by Licy L. Yanes Cardozo Breakdown of academic impact, for papers by Rok Herman Breakdown of academic impact, for papers by Ali Shamsa Breakdown of academic impact, for papers by Aditi Parulkar Breakdown of academic impact, for papers by Vishal Bhatia
Rankless by CCL
2026